These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15292944)

  • 1. Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study.
    Ficorella C; Morelli MF; Ricevuto E; Cannita K; Porzio G; Baldi PL; Cianci G; DI Rocco ZC; Natoli C; Tinari N; DE Galitiis F; Calista F; Marchetti P
    Br J Cancer; 2004 Aug; 91(4):618-20. PubMed ID: 15292944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy: a phase I, dose-finding study.
    Lortholary A; Maillard P; Delva R; Boisdron-Celle M; Perard D; Vernillet L; Besenval M; Gamelin E
    Eur J Cancer; 2000 Sep; 36(14):1773-80. PubMed ID: 10974625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study.
    Humphreys AC; Dent J; Rodwell S; Crawford SM; Joffe JK; Bradley C; Dodwell D; Perren TJ
    Br J Cancer; 2004 Jun; 90(11):2131-4. PubMed ID: 15150554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timed-flat infusion of 5-fluorouracil associated with docetaxel as first-line treatment of patients with metastatic breast cancer.
    Rispoli AI; Morelli MF; Ricevuto E; Cannita K; Santomaggio A; Mancini M; Tudini M; Cianci G; Porzio G; Lanfiuti Baldi P; Di Rocco CZ; Tinari N; Iacobelli S; Marchetti P; Ficorella C
    Breast J; 2008; 14(1):116-7. PubMed ID: 18086273
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase I study of eniluracil and oral 5-fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma.
    Rivera E; Valero V; Cristofanilli M; Frye DK; Booser DJ; Rosales MM; Hortobagyi GN
    Cancer; 2002 May; 94(9):2321-6. PubMed ID: 12015755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I dose-escalating study of 24-h continuous infusion of 5-fluorouracil in combination with weekly docetaxel and cisplatin in patients with advanced gastric cancer.
    Wang B; Zhang W; Hong X; Guo Y; Li J
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):213-8. PubMed ID: 18343924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer.
    Puglisi F; Cardellino GG; Crivellari D; Di Loreto C; Magri MD; Minisini AM; Mansutti M; Andreetta C; Russo S; Lombardi D; Perin T; Damante G; Veronesi A
    Ann Oncol; 2008 Sep; 19(9):1541-6. PubMed ID: 18441329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer.
    Park SH; Bang SM; Cho EK; Shin DB; Lee JH; Lee WK; Chung M
    BMC Cancer; 2005 Jul; 5():87. PubMed ID: 16042786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer.
    Bayet-Robert M; Kwiatkowski F; Leheurteur M; Gachon F; Planchat E; Abrial C; Mouret-Reynier MA; Durando X; Barthomeuf C; Chollet P
    Cancer Biol Ther; 2010 Jan; 9(1):8-14. PubMed ID: 19901561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer.
    Chen LT; Liu TW; Wu CW; Chung TR; Shiah HS; Jan CM; Liu JM; Whang-Peng J; Chang JY
    Oncology; 2002; 63(3):239-47. PubMed ID: 12381903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinorelbine and infusional 5-fluorouracil in anthracycline and taxane pre-treated metastatic breast cancer.
    Stuart NS; McIllmurray MB; Bishop JL; Johnston SR; Price CG; O'Reilly SM; Joffe JK; Neave F; Whipp EC
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):152-6. PubMed ID: 18083354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of docetaxel combined capecitabine on metastatic breast cancer].
    Wang XX; Zhou ZM; Yuan ZY; Zhang DS; Shi YX; Jiang WQ
    Ai Zheng; 2007 Apr; 26(4):407-10. PubMed ID: 17430662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer.
    Bayo J; Lomas M; Salvador J; Moreno A; Ruiz M; Rodríguez A; Fuentes J; Fernández-Freire A; Bernabé R; Fernández A
    Clin Transl Oncol; 2008 Dec; 10(12):817-25. PubMed ID: 19068453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial.
    Roth AD; Maibach R; Fazio N; Sessa C; Stupp R; Morant R; Herrmann R; Borner MM; Goldhirsch A; de Braud F
    Ann Oncol; 2004 May; 15(5):759-64. PubMed ID: 15111343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer.
    Bonnefoi H; Biganzoli L; Cufer T; Mauriac L; Hamilton A; Schaefer P; Piccart M
    Breast Cancer Res Treat; 2001 Nov; 70(1):55-63. PubMed ID: 11768362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes.
    Kalbakis K; Kouroussis C; Kakolyris S; Mavroudis D; Souglakos J; Agelaki S; Vamvakas L; Christodoulakis M; Stylianou K; Georgoulias V
    Br J Cancer; 2001 Sep; 85(6):798-802. PubMed ID: 11556827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel in combination with fluorouracil for advanced solid tumors.
    Burris HA
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):50-2. PubMed ID: 9364544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer.
    Ando M; Watanabe T; Sasaki Y; Ying DF; Omuro Y; Katsumata N; Narabayashi M; Tokue Y; Fujii H; Igarashi T; Wakita H; Ohtsu T; Itoh K; Adachi I; Taguchi T
    Br J Cancer; 1998 Jun; 77(11):1937-43. PubMed ID: 9667671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimize administration protocol of capecitabine plus docetaxel combination in metastatic breast cancer patients.
    Frances N; Woloch C; Marouani H; Mercier C; Iliadis A
    Curr Top Med Chem; 2012; 12(15):1665-8. PubMed ID: 22978334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.